Hypertension (Dallas, Tex. : 1979) · 2026
Hypertensive Disorders of Pregnancy and Cardiovascular-Kidney-Metabolic Syndrome.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ezzat Daniel, Pabon Maria A, Li Linke, Chang Annie, De Moor Nore, Yu Zhi, Cho So Mi Jemma, Natarajan Pradeep, Spracklen Cassandra N, LeBlanc Erin S, Eaton Charles B, LaMonte Michael J, Stefanick Marcia L, Manson JoAnn E, Parikh Nisha, Reiner Alexander P, Roh Jason D, Soria-Contreras Diana C, Hoshi Rosangela Akemi, Mora Samia, Demler Olga V, Powe Camille E, Honigberg Michael C
Аннотация
BACKGROUND: Hypertensive disorders of pregnancy (HDP) affect over 10% of pregnancies worldwide, but their association with cardiovascular-kidney-metabolic (CKM) syndrome remains unexplored.
METHODS: The present study included parous UK Biobank participants. The primary exposure was HDP history. CKM syndrome was categorized from stage 0 (no risk factors) to 4 (cardiovascular disease). Logistic regression tested the association of HDP history with CKM stage, adjusted for age, age2, race, Townsend Deprivation Index, and smoking status. Cox models evaluated progression to stage 4, in addition, adjusting for baseline CKM stage. Replication analyses were performed in the Women Health Initiative, with CKM stage assessed at 2 study visits.
RESULTS: Among 219 639 UK Biobank (mean age, 56.9 years) and 3591 Women Health Initiative participants (61.7 years at baseline, 78.1 years at the follow-up visit), 2836 (1.3%) and 304 (8.4%), respectively, had a history of HDP. In the UK Biobank, HDP history was significantly associated with higher CKM stage (adjusted odds ratio, 3.40 [95% CI, 3.12-3.71]; P<0.001) in ordinal logistic regression. Compared with CKM stage 0, HDP history was associated with higher odds of stages 2 to 4 (adjusted odds ratios, 6.34, 11.20, and 7.43, respectively; all P<0.001). Over a median follow-up of 13.6 years, prior HDP was associated with progression to stage 4 (adjusted hazard ratio, 1.24 [95% CI, 1.10-1.40]; P<0.001). Replication in the Women Health Initiative produced consistent results.
CONCLUSIONS: HDP history was associated with greater CKM stage and progression to advanced CKM syndrome, supporting its use as an early life predictor of adverse CKM trajectories.
METHODS: The present study included parous UK Biobank participants. The primary exposure was HDP history. CKM syndrome was categorized from stage 0 (no risk factors) to 4 (cardiovascular disease). Logistic regression tested the association of HDP history with CKM stage, adjusted for age, age2, race, Townsend Deprivation Index, and smoking status. Cox models evaluated progression to stage 4, in addition, adjusting for baseline CKM stage. Replication analyses were performed in the Women Health Initiative, with CKM stage assessed at 2 study visits.
RESULTS: Among 219 639 UK Biobank (mean age, 56.9 years) and 3591 Women Health Initiative participants (61.7 years at baseline, 78.1 years at the follow-up visit), 2836 (1.3%) and 304 (8.4%), respectively, had a history of HDP. In the UK Biobank, HDP history was significantly associated with higher CKM stage (adjusted odds ratio, 3.40 [95% CI, 3.12-3.71]; P<0.001) in ordinal logistic regression. Compared with CKM stage 0, HDP history was associated with higher odds of stages 2 to 4 (adjusted odds ratios, 6.34, 11.20, and 7.43, respectively; all P<0.001). Over a median follow-up of 13.6 years, prior HDP was associated with progression to stage 4 (adjusted hazard ratio, 1.24 [95% CI, 1.10-1.40]; P<0.001). Replication in the Women Health Initiative produced consistent results.
CONCLUSIONS: HDP history was associated with greater CKM stage and progression to advanced CKM syndrome, supporting its use as an early life predictor of adverse CKM trajectories.